Healio Gastroenterology Current Issue

The following articles appeared in the print edition of Healio Gastroenterology.

Table of Contents

• New Drugs and Diagnostics for IBS-D
• Ten IBD Highlights from DDW 2015
• Serrated Lesions Pose Difficulties in Detection, Treatment Farzan Fahrtash Bahin, MBBS (Hons); Michael Bourke, MBBS, FRACP
• FDA Approves Cobas KRAS Mutation Test for Metastatic Colorectal Cancer
• FDA Approves Stool Test for C. difficile
• FDA Grants Fast Track Designation to Evofosfamide for Advanced Pancreatic Cancer
• FDA Grants Orphan Drug Designation to Reolysin for Gastric Cancer
• Phase 1 Trial Initiated for First-in-Class ATPase Modulator for IBD
• IBS: Still Treating Subsets for Lack of Known Mechanisms
• HCV Consults: Volume 1, Number 3
• Few Patients With Colorectal Cancer Receive Advice on Exercise
• IBD Risk Higher in Families Already Affected by IBD
• Intraoperative Hypothermia in Colectomy Patients not Associated With Increased Risk for SSI
• Ongoing Histological Activity With Autoimmune Hepatitis Reduced Long-Term Survival
• Statins Improve SVR Rates, Lower Cirrhosis, HCC risk in HCV Therapy
• ALLY-2: Daclatasvir/Sofosbuvir Effective in HCV Patients with HIV, Cirrhosis
• BLOG: A Smartphone App to Identify At-Risk Cirrhosis Patients in 5 Minutes
• Entyvio Shows Promise in Pediatric Patients with IBD
• MEDI2070 Shows Clinical Benefit in Crohn’s Previous Treatment Failures
• Recurrent C. difficile Infection More Common in IBD Patients, Increases Risk for Colectomy
• Sexual Dysfunction More Prevalent in Men With IBD
• TOUCHSTONE Trial: Ozanimod Induces Remission in Ulcerative Colitis
• Universal Stool Donor Model for FMT Improves Screening, Reduces Costs, Delays
• Harvoni Adds Benefit for Patients With HCV/HIV Coinfection
• Stretta Claims Most Widely Used Endoluminal GERD Treatment
• WHO Releases 2015 Essential Medicines List, Including HCV Drugs